会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PORCINE TORQUE TENO VIRUS VACCINES AND DIAGNOSIS
    • 猪瘟TENO病毒疫苗及其诊断
    • WO2011031438A3
    • 2011-06-30
    • PCT/US2010046330
    • 2010-08-23
    • VIRGINIA TECH INTELL PROPMENG XIANG-JINHUANG YAOWEI
    • MENG XIANG-JINHUANG YAOWEI
    • C12N15/34A01K67/027A61K39/12C12N15/63C12Q1/68G01N33/569
    • G01N33/56983A61K39/12A61K2039/552C07K14/005C07K16/081C12N7/00C12N2750/00021C12N2750/00022C12N2750/00034C12N2750/14034C12Q1/701G01N2333/01G01N2333/085G01N2469/20
    • The present invention provides four purified preparation containing a polynucleic acid molecule encoding porcine Torque teno virus (PTTV) genotypes or subtypes PTTV1a-VA, PTTV1b-VA, PTTV2b-VA, and PTTV2c-VA. The present invention also provides infectious DNA clones, biologically functional plasmid or viral vector containing the infectious nucleic acid genome molecule of the same. The present invention further provides live, attenuated, vector-expressed and purified recombinant capsid subunit or killed viral vaccines for protection against PTTV infection. The present invention additionally provides subunit vaccines comprising PTTV specific gene products, especially ORF1 capsid gene product for protection against PTTV infection. Further, the present invention provides methods for diagnosing PTTV infection via polymerase chain reaction (PCR) using specific primer for PTTV1, PTTV2, and individual PTTV1 genotypes. Finally, the present invention provides methods for diagnosing PTTV infection via immunological methods, e.g., enzyme-linked immunoabsorbent assay (ELISA) and Western blot using PTTV specific antigens for detecting serum PTTV specific antibodies.
    • 本发明提供了四种含有编码猪扭矩型诺沃病毒(PTTV)基因型或亚型PTTV1a-VA,PTTV1b-VA,PTTV2b-VA和PTTV2c-VA的多核酸分子的纯化制剂。 本发明还提供了感染性DNA克隆,生物功能性质粒或含有其的感染性核酸基因组分子的病毒载体。 本发明进一步提供活的,减毒的,载体表达和纯化的重组衣壳亚单位或杀死的病毒疫苗以防止PTTV感染。 本发明另外提供了包含PTTV特异性基因产物的亚单位疫苗,特别是用于防止PTTV感染的ORF1衣壳基因产物。 此外,本发明提供了使用用于PTTV1,PTTV2和个体PTTV1基因型的特异性引物通过聚合酶链式反应(PCR)诊断PTTV感染的方法。 最后,本发明提供了通过免疫学方法诊断PTTV感染的方法,例如酶联免疫吸附测定(ELISA)和使用PTTV特异性抗原的Western印迹来检测血清PTTV特异性抗体。
    • 2. 发明申请
    • PORCINE TORQUE TENO VIRUS VACCINES AND DIAGNOSIS
    • 猪瘟TENO病毒疫苗及其诊断
    • WO2011031438A9
    • 2011-03-17
    • PCT/US2010/046330
    • 2010-08-23
    • VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.MENG, Xiang-JinHUANG, Yaowei
    • MENG, Xiang-JinHUANG, Yaowei
    • C12N15/34C12N15/63A61K39/12A01K67/027C12Q1/68G01N33/569
    • The present invention provides four purified preparation containing a polynucleic acid molecule encoding porcine Torque teno virus (PTTV) genotypes or subtypes PTTV1a-VA, PTTV1b-VA, PTTV2b-VA, and PTTV2c-VA. The present invention also provides infectious DNA clones, biologically functional plasmid or viral vector containing the infectious nucleic acid genome molecule of the same. The present invention further provides live, attenuated, vector-expressed and purified recombinant capsid subunit or killed viral vaccines for protection against PTTV infection. The present invention additionally provides subunit vaccines comprising PTTV specific gene products, especially ORF1 capsid gene product for protection against PTTV infection. Further, the present invention provides methods for diagnosing PTTV infection via polymerase chain reaction (PCR) using specific primer for PTTV1, PTTV2, and individual PTTV1 genotypes. Finally, the present invention provides methods for diagnosing PTTV infection via immunological methods, e.g., enzyme-linked immunoabsorbent assay (ELISA) and Western blot using PTTV specific antigens for detecting serum PTTV specific antibodies.
    • 本发明提供了含有编码猪扭矩型诺沃病毒(PTTV)基因型或亚型PTTV1a-VA,PTTV1b-VA,PTTV2b-VA和PTTV2c-VA的多核酸分子的四种纯化制剂。 本发明还提供了感染性DNA克隆,生物功能性质粒或含有其的感染性核酸基因组分子的病毒载体。 本发明进一步提供活的,减毒的,载体表达和纯化的重组衣壳亚单位或杀死的病毒疫苗以防止PTTV感染。 本发明另外提供了包含PTTV特异性基因产物的亚单位疫苗,特别是用于防止PTTV感染的ORF1衣壳基因产物。 此外,本发明提供了使用用于PTTV1,PTTV2和个体PTTV1基因型的特异性引物通过聚合酶链式反应(PCR)诊断PTTV感染的方法。 最后,本发明提供了用于通过免疫学方法诊断PTTV感染的方法,例如酶联免疫吸附测定(ELISA)和使用PTTV特异性抗原的Western印迹来检测血清PTTV特异性抗体。
    • 3. 发明申请
    • CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
    • CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep及其用途
    • WO2009128878A1
    • 2009-10-22
    • PCT/US2009/002189
    • 2009-04-08
    • VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.JUHAN, Nicole, M.MENG, Xiang-jin
    • JUHAN, Nicole, M.MENG, Xiang-jin
    • A61K39/12
    • C12N7/00A61K2039/525C12N2750/10021
    • The present invention relates to a novel chimeric nucleic acid molecule of porcine circovirus (PCV2Gen-lRep) that embraces a nucleic acid molecule encoding porcine circovirus type 2 (PCV2) which contains a nucleic acid sequence encoding a Rep protein of porcine circovirus type 1 (PCVl), particularly wherein the nucleic acid sequence encoding the Rep protein of PCVl is an open reading frame (ORF) gene and, more particularly, wherein the ORF Rep gene is ORFl. A highly desirable chimeric nucleic acid molecule is constructed by replacing the ORFl Rep gene of PCV2 by the ORFl Rep gene of PCVl. The invention also encompasses the biologically functional plasmid or viral vector containing the unique chimeric nucleic acid molecules, suitable host cells transfected by the plasmid or vector, infectious chimeric porcine circoviruses that are produced by the suitable host cells, the process for the production of an immunogenic polypeptide product making use of the new chimera, viral vaccines that protect a pig against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2, methods of protecting a pig against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2, methods of preparing the unique chimera of PCV2Gen-lRep and the like. This invention further includes a new method for improving the replication and titer of PCV2 in a cell culture.
    • 本发明涉及一种包含编码猪圆环病毒2型(PCV2)的核酸分子的猪圆环病毒嵌合核酸分子(PCV2Gen-1Rep),其包含编码猪圆环病毒1型Rep蛋白(PCV1)的核酸序列 ),特别是其中编码PCV1的Rep蛋白的核酸序列是开放阅读框(ORF)基因,更具体地,其中ORF Rep基因是ORF1。 通过用PCV1的ORF1 Rep基因替换PCV2的ORF1 Rep基因来构建非常需要的嵌合核酸分子。 本发明还包括含有独特的嵌合核酸分子,由质粒或载体转染的合适的宿主细胞的生物功能质粒或病毒载体,由合适的宿主细胞产生的感染性嵌合猪圆环病毒,产生免疫原性的方法 使用新的嵌合体的多肽产物,保护猪免受PCV2引起的病毒感染或断奶后多系统消耗综合征(PMWS)的病毒疫苗,保护猪免受病毒感染或由PCV2引起的断奶后多系统消耗综合征(PMWS)的方法, 制备PCV2Gen-lRep等独特嵌合体的方法。 本发明还包括用于改善细胞培养物中PCV2的复制和滴度的新方法。
    • 7. 发明申请
    • PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
    • PORCINE DC-SIGN,ICAM-3和LSECtin及其用途
    • WO2009058285A2
    • 2009-05-07
    • PCT/US2008/012251
    • 2008-10-29
    • VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.HUANG, YaoweiMENG, Xiang-Jin
    • HUANG, YaoweiMENG, Xiang-Jin
    • C07K14/43
    • C07K14/70525C07K14/7056
    • The present invention relates to the cloning, identification and characterization of the unique and entire genomic sequences encoding new porcine DC-SIGN and LSECtin proteins, including the novel nucleotide sequences of the full-length cDNA and genes of both pDC- SIGN gene and pLSECtin. Also provided are the nucleic acid molecules encoding newly discovered porcine ICAM-3 isoforms from porcine monocyte-derived dendritic cells and the use thereof. Specifically, the invention is drawn to an isolated nucleic acid molecule comprising a nucleotide sequence encoding one or more of porcine DC-SIGN, porcine ICAM- 3, porcine LSECtin, a complement of the nucleotide sequence or a functional, defined portion of the nucleotide sequence or a protein fusion product linked to a protein that may be of porcine or human origin. Methods for isolating and cloning the new porcine genes and for using the new nucleotide sequences in improved methods for propagating viruses, particularly enveloped viruses, are additionally described herein. The invention further includes new transfected cells or cell lines that can stably express the porcine proteins, new antibodies and the like.
    • 本发明涉及克隆,鉴定和表征编码新的猪DC-SIGN和LSECtin蛋白的独特和完整的基因组序列,包括全长cDNA的新型核苷酸序列和 pDC-SIGN基因和pLSECtin。 还提供了编码来自猪单核细胞来源的树突细胞的新发现的猪ICAM-3同种型的核酸分子及其用途。 具体而言,本发明涉及包含编码猪DC-SIGN,猪ICAM-3,猪LSECtin,核苷酸序列的互补序列或核苷酸序列的功能性限定部分中的一种或多种的核苷酸序列的分离的核酸分子 或与可能是猪或人来源的蛋白质连接的蛋白质融合产物。 本文额外描述了用于分离和克隆新猪基因的方法以及用于改进繁殖病毒特别是有包膜病毒的方法中的新核苷酸序列的方法。 本发明还包括可稳定表达猪蛋白质的新转染细胞或细胞系,新抗体等。
    • 8. 发明申请
    • NOVEL MODIFIED LIVE-ATTENUATED VACCINES (MLV) AND SUBUNIT VACCINES CREATED BY DNA SHUFFLING AGAINST PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV)
    • 新型改良的活体灭活疫苗(MLV)和亚硝酸盐灭活剂对磷酸盐生殖和呼吸道综合症病毒(PRRSV)
    • WO2011153351A3
    • 2012-06-28
    • PCT/US2011038930
    • 2011-06-02
    • VIRGINIA TECH INTELL PROPNI YANYANHUANG YAO-WEIMENG XIANG-JIN
    • NI YANYANHUANG YAO-WEIMENG XIANG-JIN
    • C12N15/40A61K39/12A61P31/14C12N15/62C12N15/63
    • A61K39/12A61K2039/5254A61K2039/552C12N7/00C12N2770/10034C12N2770/10052
    • The present invention provides a novel infectious cDNA clone of porcine reproductive and respiratory syndrome virus (PRRSV), particularly for PRRSV strain VR2385; an improved DNA-launched reverse genetics system for PRRSV; infectious chimeric PRRSV viruses generated through DNA shuffling; modified live- attenuated virus vaccines (MLV) using DNA shuffled chimeric viruses; chimeric viral proteins produced through shuffled chimeric viruses; PRRSV antigens and subunit vaccines based on shuffled chimeric viral proteins; and method of producing broadly protective PRRSV vaccines using DNA shuffling techniques. Particularly, the present invention provides infectious chimeric viruses generated by DNA shuffling of the GP5 genes of genetically distinct strains of PRRSV; modified live-attenuated vaccines comprise infectious chimeric viruses containing the shuffled GP5 genes and/or other shuffled PRRSV proteins (such as GP2, GP3, GP4, M, and non- structural proteins); broadly -protective subunit vaccines comprising PRRSV chimeric shuffled GP5 protein and/or other shuffled PRRSV proteins (such as GP2, GP3, GP4, M, and non- structural proteins).
    • 本发明提供猪繁殖与呼吸综合征病毒(PRRSV)的新型感染性cDNA克隆,特别是PRRSV株VR2385的感染性cDNA克隆; 用于PRRSV的改进的DNA推出的反向遗传学系统; 通过DNA改组产生的感染性嵌合PRRSV病毒; 使用DNA洗牌嵌合病毒的改良活减毒病毒疫苗(MLV); 通过混洗嵌合病毒产生的嵌合病毒蛋白; 基于混洗嵌合病毒蛋白的PRRSV抗原和亚单位疫苗; 以及使用DNA改组技术生产广泛保护性PRRSV疫苗的方法。 特别地,本发明提供了通过遗传上不同的PRRSV菌株的GP5基因的DNA改组产生的感染性嵌合病毒; 修饰的活减毒疫苗包括含有洗牌的GP5基因和/或其它改组的PRRSV蛋白(例如GP2,GP3,GP4,M和非结构蛋白)的感染性嵌合病毒; 包括PRRSV嵌合洗牌的GP5蛋白和/或其它改组的PRRSV蛋白(例如GP2,GP3,GP4,M和非结构蛋白)的广泛保护性亚单位疫苗。
    • 9. 发明申请
    • NOVEL MODIFIED LIVE-ATTENUATED VACCINES (MLV) AND SUBUNIT VACCINES CREATED BY DNA SHUFFLING AGAINST PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV)
    • 新型改良的活体灭活疫苗(MLV)和亚硝酸盐灭活剂对磷酸盐生殖和呼吸道综合症病毒(PRRSV)
    • WO2011153351A2
    • 2011-12-08
    • PCT/US2011/038930
    • 2011-06-02
    • VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.NI, YanyanHUANG, Yao-WeiMENG, Xiang-Jin
    • NI, YanyanHUANG, Yao-WeiMENG, Xiang-Jin
    • C12N15/40C12N15/63C12N15/62A61K39/12A61P31/14
    • A61K39/12A61K2039/5254A61K2039/552C12N7/00C12N2770/10034C12N2770/10052
    • The present invention provides a novel infectious cDNA clone of porcine reproductive and respiratory syndrome virus (PRRSV), particularly for PRRSV strain VR2385; an improved DNA-launched reverse genetics system for PRRSV; infectious chimeric PRRSV viruses generated through DNA shuffling; modified live- attenuated virus vaccines (MLV) using DNA shuffled chimeric viruses; chimeric viral proteins produced through shuffled chimeric viruses; PRRSV antigens and subunit vaccines based on shuffled chimeric viral proteins; and method of producing broadly protective PRRSV vaccines using DNA shuffling techniques. Particularly, the present invention provides infectious chimeric viruses generated by DNA shuffling of the GP5 genes of genetically distinct strains of PRRSV; modified live-attenuated vaccines comprise infectious chimeric viruses containing the shuffled GP5 genes and/or other shuffled PRRSV proteins (such as GP2, GP3, GP4, M, and non- structural proteins); broadly -protective subunit vaccines comprising PRRSV chimeric shuffled GP5 protein and/or other shuffled PRRSV proteins (such as GP2, GP3, GP4, M, and non- structural proteins).
    • 本发明提供猪繁殖与呼吸综合征病毒(PRRSV)的新型感染性cDNA克隆,特别是PRRSV株VR2385的感染性cDNA克隆; 用于PRRSV的改进的DNA推出的反向遗传学系统; 通过DNA改组产生的感染性嵌合PRRSV病毒; 使用DNA洗牌嵌合病毒的改良活减毒病毒疫苗(MLV); 通过混洗嵌合病毒产生的嵌合病毒蛋白; 基于混洗嵌合病毒蛋白的PRRSV抗原和亚单位疫苗; 以及使用DNA改组技术生产广泛保护性PRRSV疫苗的方法。 特别地,本发明提供了通过遗传上不同的PRRSV菌株的GP5基因的DNA改组产生的感染性嵌合病毒; 修饰的活减毒疫苗包括含有洗牌的GP5基因和/或其它改组的PRRSV蛋白(例如GP2,GP3,GP4,M和非结构蛋白)的感染性嵌合病毒; 包括PRRSV嵌合洗牌的GP5蛋白和/或其它改组的PRRSV蛋白(例如GP2,GP3,GP4,M和非结构蛋白)的广泛保护性亚单位疫苗。
    • 10. 发明申请
    • PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
    • PORCINE DC-SIGN,ICAM-3和LSECtin及其用途
    • WO2009058285A3
    • 2009-12-10
    • PCT/US2008012251
    • 2008-10-29
    • VIRGINIA TECH INTELL PROPHUANG YAOWEIMENG XIANG-JIN
    • HUANG YAOWEIMENG XIANG-JIN
    • C07K14/705
    • C07K14/70525C07K14/7056
    • The present invention relates to the cloning, identification and characterization of the unique and entire genomic sequences encoding new porcine DC-SIGN and LSECtin proteins, including the novel nucleotide sequences of the full-length cDNA and genes of both pDC- SIGN gene and pLSECtin. Also provided are the nucleic acid molecules encoding newly discovered porcine ICAM-3 isoforms from porcine monocyte-derived dendritic cells and the use thereof. Specifically, the invention is drawn to an isolated nucleic acid molecule comprising a nucleotide sequence encoding one or more of porcine DC-SIGN, porcine ICAM- 3, porcine LSECtin, a complement of the nucleotide sequence or a functional, defined portion of the nucleotide sequence or a protein fusion product linked to a protein that may be of porcine or human origin. Methods for isolating and cloning the new porcine genes and for using the new nucleotide sequences in improved methods for propagating viruses, particularly enveloped viruses, are additionally described herein. The invention further includes new transfected cells or cell lines that can stably express the porcine proteins, new antibodies and the like.
    • 本发明涉及克隆,鉴定和表征编码新的猪DC-SIGN和LSECtin蛋白的独特和完整的基因组序列,包括全长cDNA的新型核苷酸序列以及pDC-SIGN基因和pLSECtin的基因。 还提供了编码来自猪单核细胞来源的树突细胞的新发现的猪ICAM-3同种型的核酸分子及其用途。 具体而言,本发明涉及包含编码猪DC-SIGN,猪ICAM-3,猪LSECtin,核苷酸序列的互补序列或核苷酸序列的功能性限定部分中的一种或多种的核苷酸序列的分离的核酸分子 或与可能是猪或人来源的蛋白质连接的蛋白质融合产物。 本文额外描述了用于分离和克隆新猪基因的方法以及用于改进繁殖病毒特别是有包膜病毒的方法中的新核苷酸序列的方法。 本发明还包括可稳定表达猪蛋白质的新转染细胞或细胞系,新抗体等。